Clinical trial
Efficacy of Dexmedetomidine Versus Magnesium Sulfate as Adjuvants to Intraperitoneal Bupivacaine for Postoperative Analgesia in Patients Undergoing Elective Laparoscopic Cholecystectomy
NCT06879288 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Dexmedetomidine Versus Magnesium Sulfate as Adjuvants to Intraperitoneal Bupivacaine for Postoperative Analgesia in Patients Undergoing Elective Laparoscopic Cholecystectomy
- Lead sponsor
- Tanta University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 1, 2023
- Completion date
- February 1, 2025
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adjuvants, dexmedetomidine, elective laparoscopic cholecystectomy, intraperitoneal bupivacaine, magnesium sulfate, postoperative analgesia